\u201cNice quickly emerged as the right choice due to its talent pool which enabled us to develop our business activities here, in particular in technical terms.\u201d<\/p>\n
Alan Howard, CEO of the European Society for Medical Oncology 2012, European Society for Medical Oncology<\/p>\n
***<\/p>\n
\u201cWe had two sites, one which we rented in Mougins and the other, which we own, in Valbonne. Bringing the teams of both sites together, a total of 161 people and seizing this opportunity to redevelop and renovate our premises with a \u20ac2.2 M investment is a measure of our lasting future and demonstrates the Group\u2019s commitment to continue its development in Sophia Antipolis [\u2026].In Sophia Antipolis we have a genuine expertise in polymers in aqueous media.\u201d<\/p>\n
Andrew Trapani, Director of the Innovation Center of Valbonne \u2013 Sophia Antipolis \u2013 2015, Dow France<\/p>\n
***<\/p>\n
\u201cHigh quality of life, pleasant climate, international environment, the airport, highly skilled labour: the C\u00f4te d\u2019Azur is a fantastic place.\u201d<\/p>\n
Bo Hilligsoe, CEO \u2013 2010, Lundbeck<\/p>\n
***<\/p>\n
\u201cI could have located my start up anywhere in France, but I chose Nice because it is much easier and agreeable to work here than in Paris.\u201d<\/p>\n
Claude Laruelle, CEO \u2013 2002, CLL Pharma<\/p>\n
***<\/p>\n
Team C\u00f4te d\u2019Azur assisted Sofia Cosm\u00e9tique in obtaining a Regional Hiring Grant (Prime d\u2019Am\u00e9nagement du Territoire) for our investments in Carros. Constant support, relevant information and valuable advice enabled us to focus on the key points and be sure of securing the PAT.
\nWe are fully satisfied with the support we received.<\/p>\n
Alexandre Dingas\u2013 2015, Sofia Cosm\u00e9tique<\/p>\n
***<\/p>\n
Our laboratory at Grasse was unveiled in March 2015 in an ideal setting that not only facilitated marketing our services but also welcomed our customers\u2026Team C\u00f4te d\u2019Azur helped us build a network by way of several themed meetings.These meetings were all well-organized and created an easy environment for initial contact between professionals. The goal of our laboratory at Grasse is to develop strong partnerships with regional companies such as Agences R\u00e9gionales de Sant\u00e9 (Regional Health Agencies), as well as manufacturers and communities to help them to conform to all the rules and regulations. Our mission to assure a quality service and a lab that employs at least ten people.<\/p>\n
Fran\u00e7ois Balavoine, Business Unit Manager Eurofins, Grasse<\/p>\n
***<\/p>\n
\u201cThe Grasse region has lived and thought perfume at every level ? from the supply of raw materials and the creation of flavors to mastery of logistics.\u201d<\/p>\n
Jean-Claude Gigodot, Founder And Managing Director \u2013 2003, Sentaromatique<\/p>\n
***<\/p>\n
\u201cGrasse is the traditional heart of the perfumery industry and a great market for us to develop our activity.\u201d
\nManan Gandhi, Director \u2013 2013, Associate Allied Chemicals (AAC)<\/p>\n
***<\/p>\n
\u201cThere are a number of experienced people in Sophia Antipolis with the, know-how and experience for improving silicone technology.\u201d<\/p>\n
Patrick Peignot, Technical Director, Nusil<\/p>\n
***<\/p>\n
\u201cSophia Antipolis is the most important technopole in Europe and we wanted to be associated with an environment that complemented our high-tech image.\u201d<\/p>\n
Valentin Gitto, Business Development Director \u2013 2001, LPG Systems<\/p>\n
***<\/p>\n
\u201cGalderma maintains a close working relationship with the INRIA teams through research work on the mathematical models involved in image processing, essential for improving the readability of symptoms. Furthermore, the presence of INPI is also interesting. To protect its discoveries, Galderma has filed over 50 new sets of patent applications (covering new molecules, formulations, dermatological indications and some manufacturing processes) thus making it the company filing the most patents in the Alpes-Maritimes and the second largest in the PACA region\u201d, explains Fr\u00e9d\u00e9ric Fourquin, former CERAM student (now SKEMA), Manager of the Sophia Antipolis site.<\/p>\n
About Galderma
\nA world leading medical company exclusively focused on dermatology, Galderma, founded in 1981, is committed to delivering innovative medical solutions to meet the dermatological needs of people throughout their lifetime while serving healthcare professionals around the world. The company has 31 wholly-owned affiliates with a worldwide network of distributors and more than 4,000 employees. Galderma\u2019s extensive product portfolio is available in 70 countries and treats a range of dermatological conditions including: acne, rosacea, onychomycosis, psoriasis & steroid-responsive dermatoses, pigmentary disorders, skin cancer and medical solutions for skin senescence.<\/p>\n","protected":false},"excerpt":{"rendered":"
Alan Howard, European Society for Medical Oncology \u201cNice quickly emerged as the right choice due to its talent pool which enabled us to develop our business activities here, in particular in technical terms.\u201d Alan Howard, CEO of the European Society for Medical Oncology 2012, European Society for Medical Oncology *** Andrew Trapani, Dow France \u201cWe […]<\/p>\n","protected":false},"author":19,"featured_media":1769,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mi_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0},"categories":[96,103,110],"tags":[],"acf":[],"yoast_head":"\n